Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma
The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Slayback Pharma
Slayback Pharma announces investment of $50 million by The Everstone Group
The new capital will be used to expand and accelerate further Slayback’s pipeline of complex generic and specialty pharmaceutical…
Complex generics – An insight
Dr Girish Jain, Head- Global R&D, Slayback Pharma and a veteran in the field of pharma R&D gave a very informative session…